And keep an eye out for an exciting refresh of our homepage that’s now underway. We’re building a sprawling program to engage our community, including STAT Locals, a series of gatherings across the country where we’ve connected our readers. And next year, STAT is deploying its first reporter overseas, responding to readers who have been clamoring for coverage from Europe.īeyond written words, this year we’ve introduced 140 new products, including STAT Trials Pulse, a one-of-a-kind clinical intelligence platform that alerts users to real-time changes based on proprietary event classifications developed in collaboration with STAT reporters. You’ll see the publication of a project - more than two years in the making - on the prison system’s failure to respond to a deadly but preventable public health crisis. Wade and the issue of what the health care system is - or isn’t - doing writ large to limit carbon emissions. In coming months, you’ll see more fruits of our determination to cover two topical stories: the consequences of the Supreme Court’s decision to overturn Roe v.
We also published a special report from Matthew Herper, who drew on his two decades as one of the most respected journalists covering the field to explain why we’re not prepared for the next wave of biotech innovation. This week alone, our standouts include an investigation of a private equity firm relentlessly pursuing profits, to the detriment of patients, and an examination of why it’s taken years for the FDA to scrutinize pulse oximeters, which can be less accurate for people with darker skin. Exclusive analysis of biotech, pharma, and the life sciences Learn More
0 kommentar(er)
